Lynparza demonstrated clinically meaningful prolonged survival benefit in early breast cancer in OlympiA Phase 3 trial
First and only PARP inhibitor to improve overall survival in early breast cancer
First and only PARP inhibitor to improve overall survival in early breast cancer
CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US
Emcure has launched an awareness campaign to help spread the word about male anemia
Aromatic L-amino acid decarboxylase deficiency is a rare genetic disorder that affects the production of some neurotransmitters
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Data demonstrate the importance of protecting against serious respiratory infections caused by respiratory syncytial virus, human metapneumovirus and COVID-19
Enhertu demonstrated clinically meaningful efficacy in previously treated patients
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
A multi-disciplinary team of senior physicians opted to use Zidebactam/Cefepime under compassionate use
Subscribe To Our Newsletter & Stay Updated